Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

10-year study shows tomosynthesis improves breast cancer detection

2.

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

3.

Microplastics can cause malignant changes in lung cells

4.

The Kansas Cancer Center awarded two Indian American doctors professorships.

5.

Two medications might work better for breast cancers that are resistant to one.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot